LRE Medical

What LRE Medical does

LRE Medical GmbH is a privately held German Contract Development and Manufacturing Organization (CDMO) specializing in point-of-care diagnostic instruments and complex in-vitro diagnostic (IVD) analyzers, with secondary reach into benchtop molecular diagnostics and life sciences devices. Founded in 1964 and headquartered in Nördlingen with a secondary office in Munich, the company delivers end-to-end services across four pillars: Product Development and Engineering, Production Engineering and Manufacturing, Quality and Regulatory Support, and Lifecycle Management and After-Sales Service. Core technical competencies include Design for Manufacturability/Assembly/Test integration, prototype-to-serial-production ramp-up under a gated stage process, and full regulatory compliance for global medical device market access. The company reports 60+ years of R&D experience, zero product recalls across its history, and a 17-year average client tenure.

The business model is project-based contract development combined with serial manufacturing under long-term supply agreements and recurring lifecycle management revenue. LRE serves enterprise medical device OEMs, IVD companies (including QIAGEN and QuidelOrtho), and emerging diagnostics ventures (such as deepull), with case studies spanning point-of-care infectious disease molecular diagnostics, cardiac biomarker systems, qPCR-based platforms with optics integration, and rapid PCR for sepsis care. Pricing is quote-based and negotiated per project, with no public pricing disclosures. Go-to-market is sales-led through direct enterprise engagement, supported by a corporate website, case-study content marketing, and industry event participation. The firm does not sell standalone products; revenue is generated exclusively through service engagements tied to client device programs.

The company is privately held with no disclosed parent company, no known institutional investors, no funding rounds on record, and no M&A or leadership transitions disclosed. Geographic reach is described as global from a German manufacturing base, though operational footprint is currently limited to two German sites. The combination of long customer tenures, zero-recall track record, and integrated lifecycle offerings forms the core of LRE's positioning versus competing CDMOs, while the absence of disclosed AI/ML capability, revenue figures, and headcount trends limits external visibility into its current scale and growth trajectory.

Name

LRE Medical

Legal name

LRE Medical GmbH

Website

https://lre.de

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

101–250 employees

Short description

LRE Medical GmbH is a German Contract Development and Manufacturing Organization (CDMO) that develops and serial-produces point-of-care diagnostic instruments and complex IVD analyzers for medical device OEMs, IVD companies, and diagnostics ventures across full product lifecycles.

Ownership category

akta.pro rank

Headquarters

HQ city

Nördlingen

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Development Services: Product development and engineering services including concept development, design input, prototyping, and verification. Revenue generated through project-based development fees.
2. Contract Manufacturing Services: Serial production and manufacturing of diagnostic and medical devices. Revenue generated through per-unit manufacturing fees and long-term supply agreements with medical device OEM partners.
3. Lifecycle Management Services: After-sales support, obsolescence management, and change management services throughout the product lifecycle, generating recurring service revenue.
4. Regulatory and Quality Support: Quality management and regulatory compliance support services bundled with development and manufacturing engagements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

LRE Medical is a German Contract Development and Manufacturing Organization (CDMO) providing end-to-end services for the development, industrialization, and lifecycle management of complex point-of-care and benchtop diagnostic, medical, and life sciences devices. The company delivers four core service pillars — Product Development & Engineering, Production Engineering & Manufacturing, Quality & Regulatory Support, and Lifecycle Management & After-Sales Service — organized around two solution areas: Point-of-Care Instruments and Complex IVD Analyzers. LRE acts as a full-service partner from initial concept through serial production for medical device OEMs, IVD companies, and life sciences organizations.

Product overview

LRE Medical operates as a CDMO (Contract Development and Manufacturing Organization) providing end-to-end services for the development and industrialization of point-of-care and benchtop diagnostic, medical, and life sciences devices. The company does not sell standalone products; instead, it offers a unified portfolio of service offerings organized across two solution categories—Point-of-Care Instruments and Complex IVD Analyzers—supported by four core service pillars: Product Development & Engineering, Production Engineering & Manufacturing, Quality & Regulatory Support, and Lifecycle Management & After-Sales Service. LRE Medical acts as a full-service partner from initial concept through serial production, enabling clients to bring diagnostic and medtech innovations to market with German-engineered precision and regulatory compliance.

Differentiator

Problem solved

Functional benefit

Products and services

• Product Development & Engineering

Quantifiable outcome

• Time-to-market acceleration of 6-12 months
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• QIAGENcoreStrategic or Co-development PartnerCase study partner for point-of-care molecular diagnostics infectious disease testing platform development. LRE Medical provided end-to-end development and manufacturing services for QIAGEN's rapid molecular testing platform.
• QuidelOrthocoreStrategic or Co-development PartnerCase study partner for cardiac biomarker system development. LRE Medical supported the development of point-of-care instruments for rapid cardiac diagnostics testing.
• deepullcoreStrategic or Co-development PartnerCase study partner for developing a fully automated rapid PCR system for direct-from-blood pathogen detection to accelerate sepsis care. LRE Medical contributed product development and manufacturing expertise.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Sanmina: Global contract manufacturer with dedicated medical and diagnostics capabilities. Overlapping customer base and program profile (IVD analyzers, point-of-care devices) make it a comparable CDMO for OEM outsourcing decisions.
• Jabil Healthcare: Division of Jabil, one of the largest global manufacturing services providers, with a substantial medical device, IVD, and diagnostics practice. Competes on medical device and IVD contract manufacturing at greater scale and geographic reach.
• Celestica HealthTech: EMS/CDMO with a HealthTech segment serving diagnostic and medical device OEMs. Competes for IVD and analytical instrument programs with global scale and regulatory expertise comparable to LRE.
• Stevanato Group: Global provider of drug containment, medical device, and diagnostic instrument solutions with contract manufacturing capabilities. Adjacent in serving IVD and medical device OEMs with engineering and manufacturing services.
• Flex (Flextronics) Health Solutions: Global EMS/CDMO with significant medical and diagnostics manufacturing services, including design, engineering, and serial production for IVD and medtech OEMs. Larger competitor with multi-region footprint.

Direct peers

• Phillips-Medisize: Global medical device CDMO offering design, development, and manufacturing services across drug delivery, IVD, and diagnostics. Competes for the same OEM outsourcing programs as LRE, with broader geographic footprint.
• Stratec SE: German-based developer and manufacturer of fully automated analyzer systems for the IVD and life sciences industry. Direct peer: similar German CDMO model for analytical/diagnostic instruments, same OEM customer archetype.
• Tecan Group: Swiss OEM and CDMO partner for IVD/life-science instruments, including laboratory automation and molecular diagnostics platforms. Highly comparable in customer archetype (IVD and life science OEMs) and product focus (benchtop analyzers).

Regional players

• Gerresheimer: German-headquartered manufacturer of specialty glass and plastics for pharma and diagnostics, with growing medical devices and IVD adjacencies. Same German home market, overlapping IVD OEM relationships, and engineering-driven positioning.

Emerging players

• Eurofins Genomics / Eurofins CDMO: Eurofins operates CDMO and life sciences services adjacent to diagnostics. Partial overlap in molecular diagnostics and life sciences contract services makes it a relevant adjacent competitor for OEM work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/lre-medical-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LRE Medical